Emcyt and Insomnia exacerbated - a phase IV clinical study of FDA data

Summary:

Insomnia exacerbated is reported as a side effect among people who take Emcyt (estramustine phosphate sodium), especially for people who are male, 40-49 old, also take Zometa, and have Prostate cancer.

The phase IV clinical study analyzes which people have Insomnia exacerbated when taking Emcyt. It is created by eHealthMe based on reports of 507 people who have side effects when taking Emcyt from the FDA, and is updated regularly.

What is Emcyt?

Emcyt has active ingredients of estramustine phosphate sodium. eHealthMe is studying from 508 Emcyt users. Check the latest studies of Emcyt.

What is Insomnia exacerbated?

Insomnia exacerbated (severe sleeplessness) is found to be associated with 2,653 drugs and 975 conditions by eHealthMe. Check the latest studies of Insomnia exacerbated.

On Jul, 15, 2026

507 people reported to have side effects when taking Emcyt.
Among them, 22 people (4.34%) have Insomnia exacerbated.

Among these 22 people:

What is the gender of people who have Insomnia exacerbated when taking Emcyt? *

female: 9.09 %
male: 90.91 %

What is the age of people who have Insomnia exacerbated when taking Emcyt? *

What are other drugs people take besides Emcyt? *

What are other side effects people have besides Insomnia exacerbated? *

Pain: 21 people, 95.45%
Stress And Anxiety: 21 people, 95.45%
Pain In Jaw: 21 people, 95.45%
Weakness: 20 people, 90.91%
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect): 20 people, 90.91%
Bone Disorder: 20 people, 90.91%
Urinary Tract Infection: 20 people, 90.91%
Impaired Healing: 20 people, 90.91%
Osteonecrosis Of Jaw (death of bone of jaw): 16 people, 72.73%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 16 people, 72.73%

What are the existing conditions these people have? *

Prostate Cancer: 20 people, 90.91%
Weakness: 10 people, 45.45%
Hypoaesthesia (reduced sense of touch or sensation): 10 people, 45.45%
Pain: 5 people, 22.73%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 1 person, 4.55%
Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 1 person, 4.55%

* Approximation only. Some reports may have incomplete information.

Do you take Emcyt and have Insomnia exacerbated?

- Check whether Insomnia exacerbated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Emcyt:

Emcyt (508 reports)

Browse all side effects of Emcyt:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Insomnia exacerbated:

Insomnia exacerbated (2,653 drugs)

Browse all the conditions that are associated with Insomnia exacerbated:

Insomnia exacerbated (975 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on estramustine phosphate sodium (the active ingredients of Emcyt) and Emcyt (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.